MindBio Therapeutics

MindBio TherapeuticsMindBio Therapeutics
MindBio Therapeutics

MindBio Therapeutics

AI-powered voice analysis for non-invasive drug and alcohol intoxication detection.

Website
DR 322021ActiveMelbourne, Australia
Rate
Advertise here

About

MindBio Therapeutics develops and commercializes AI-powered health prediction technologies that transform human voice into actionable health intelligence. Their proprietary platform analyzes acoustic biomarkers in speech to detect drug and alcohol intoxication, with applications in both consumer and enterprise markets, particularly for safety-critical industries.
Frequently asked

What does MindBio Therapeutics do?

MindBio Therapeutics develops and commercializes AI-powered health prediction technologies that transform human voice into actionable health intelligence. Their proprietary platform analyzes acoustic biomarkers in speech to detect drug and alcohol intoxication, with applications in both consumer and enterprise markets, particularly for safety-critical industries.

What is MindBio Therapeutics's revenue?

StartupHub estimates MindBio Therapeutics's annual revenue at $392K (range $132K to $660K, 29% confidence), based on comparable companies in the sector.

What is MindBio Therapeutics's valuation?

StartupHub estimates MindBio Therapeutics's effective valuation at $6.7M (range $4.4M to $10.5M, 21% confidence), based on comparable companies in the sector.

How much funding has MindBio Therapeutics raised?

MindBio Therapeutics has raised a total of $2M in funding. The most recent round on record is Private Placement.

Where is MindBio Therapeutics headquartered?

MindBio Therapeutics is headquartered in Melbourne, Australia.

When was MindBio Therapeutics founded?

MindBio Therapeutics was founded in 2021.

What industry does MindBio Therapeutics operate in?

MindBio Therapeutics operates in HealthTech, MedTech, AI-Driven Drug Discovery, Clinical Trials, Mental Health Tech, Biotech.

Comments

No comments yet. Be the first to share your take.